Key result
FFR-guided angioplasty significantly reduced the number of stents per lesion compared to angiography (0.45 vs 1.05; p=0.0001) with comparable cost-effectiveness.
Why the study?
Does FFR-guided angioplasty improve clinical outcomes and cost-effectiveness compared to angiography-guided angioplasty in patients with multivessel disease?
Population
69 patients with multivessel disease, mean age 62.0 ± 9.0 years, 68.1% men.
Comparison
Fractional flow reserve-guided angioplasty using… vs Angiography-guided angioplasty using…
Design
RCT, prospectively randomized
Follow-up
< 12 months
Authors
Loading...
Supports FFR to minimize stents in multivessel disease without added cost; extends RCT evidence for physiology-guided PCI.
RCT (n=69)
prospectively randomized
Does FFR-guided angioplasty improve clinical outcomes and cost-effectiveness compared to angiography-guided angioplasty in patients with multivessel disease?
FFR-guided PCI in multivessel disease reduces the number of stents deployed without compromising clinical outcomes or cost-effectiveness compared to angiography alone.
Quintella et al. (2018) conducted an RCT in Multivessel disease with moderate stenosis (n=69). FFR-guided angioplasty vs. Angiography-guided angioplasty was evaluated on Major adverse cardiac events (MACE), restenosis and cost-effectiveness (CE). FFR-guided angioplasty significantly reduced the number of stents per lesion compared to angiography (0.45 vs 1.05; p=0.0001) with comparable cost-effectiveness.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: